- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
9
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
9 companies
Abbott India
Market Cap: ₹624.0b
Operates as a pharmaceutical company in India.
500488
₹29,366.35
7D
-1.1%
1Y
0.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹450.9b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,661.50
7D
0.2%
1Y
2.5%
Sanofi India
Market Cap: ₹109.5b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹4,752.65
7D
0.1%
1Y
-28.3%
Blue Jet Healthcare
Market Cap: ₹105.2b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹606.65
7D
-5.0%
1Y
20.5%
RPG Life Sciences
Market Cap: ₹40.7b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,462.60
7D
3.6%
1Y
-6.5%
Influx Healthtech
Market Cap: ₹4.4b
Operates as a contract development and manufacturing organization that provides a range of healthcare products in India.
INFLUX
₹190.65
7D
9.2%
1Y
n/a
Genesis IBRC India
Market Cap: ₹2.2b
Does not have significant operations.
514336
₹170.90
7D
10.4%
1Y
978.2%
Asston Pharmaceuticals
Market Cap: ₹703.6m
Manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries.
544445
₹82.65
7D
1.9%
1Y
n/a
Accretion Pharmaceuticals
Market Cap: ₹630.8m
Engages in the manufacturing and marketing of pharmaceutical products in India.
ACCPL
₹56.75
7D
0%
1Y
n/a